|
|
 |
|
Viewing report
|
|
 |
 |
NeoCardiogenesis- Celebrating The Birth Of Regenerative Cardiology
MRI Limited (Meta Reports), Nov 2008, Pages: 312
AB INITIO
Chapter 1: EXECUTIVE SUMMARY I.A Reasons For Conducting The Study I.B Study Goals & Objectives I.C Target Audience I.D Sponsorships I.E Scope & Format I.F Methodology I.G Information Sources I.H Related Projects By This Publisher I.I Conclusion
Chapter 2: The Industry II.A CAD - The Problem II.B CAD - The Current Solutions II.C CAD - More Problems – The Triple Paradox of Revascularization II.D CAD - The Unmet Need II.E CAD - NeoCardiogenesis - The Next Frontier
Chapter 3: The Folkman Hypothesis III.A History And Evolution Of The Angiogenesis Phenomenon III.B Angiogenesis and Diseases III.C The Angiogenesis Modulators III.D The Initial Successes III.E Indications Beyond Cancers- Therapeutic Angiogenesis III.F Indications Beyond Cancers- Diagnostics
Chapter 4: FOLKMAN LEGACY – Therapeutic Angiogenesis IV.A Myocardial Reperfusion IV.B Myocardial Regeneration IV.C Plaque Regression IV.D Tackling Obesity – Another Folkman Hypothesis Coming Of Age IV.E Angiogenic Switch – Folkman Legacy Continues
Chapter 5: CHANGE OF HEART – Neocardiogenesis: The New Paradigm V.A All Roads Lead To Bone Marrow V.B Residential CSC Pool V.C Cardiac Regeneration – Blend of Myogenesis & Angiogenesis V.D Broken Hearts May Mend After All?
Chapter 6: STEM CELLS – The Regeneration Revolution VI.A Stemness VI.B Stem Cell Regulation VI.C Stem Cell Niches VI.D Regenerating Heart
Chapter 7: CARDIO CANONS – The Master Regulators VII.A The HIF Pathway VII.B The PGC-8 Pathway VII.C Notch, Wnt/ß-catenin, Hedgehog & Other Pathways VII.D The Neocardiogenesis Cascade VII.E The Angiogenic Switch
Chapter 8: CLINICAL TRIALS - The First Wave VIII.A Of Bulls & Bears VIII.B Gene Therapy Trials VIII.C Protein Therapy Trials VIII.D Cell Therapy Trials
Chapter 9: SECOND WAVE – The Gold Rush IX.A State Of The Cell Therapy Trials IX.B The Bulls Are Back? IX.C Select Ongoing Trials IX.D Looking Forward
Chapter 10: THE PLACEBO EFFECT – The Specter Still Haunting? X.A Is Angiogenesis Therapy Dead? X.B Myogenesis – Placebo Effect Still Riding High? X.C The Placebo X.D The Hrobjartsson Test X.E Biggest Placebo Effect Of All Time That Sired A Nobel Prize & A Blockbuster Drug X.F Searching For The Real Culprit X.G Is Angiogenesis Therapy Dead?
Chapter11: TRANSLATIONAL PARADOX – Neocardiogenesis: A Whole Different Ballgame XI.A Mother Nature’s Secret XI.B Hypoxia Vs Normoxia – The Homeostatic Balance XI.C Hypoxia – Lost In Translation? XI.D Normoxia - Impact On Neocardiogenesis Modulators XI.E Translational Paradox – Secrets Revealed
Chapter 12: CATCH 22- Obsolescence Of Convention XII.A Simpson’s Paradox XII.B The Intrinsic Confounders XII.C The Extrinsic Confounders XII.D The Clinical Protocols XII.E The Treadmill Fallacies – Of Apples & Oranges XII.F Myocardial Preconditioning XII.G Obsolescence Of Convention XII.H Catching Up With The Triple Cripple
Chapter 13: WAY OUT- Ridding The Triple Cripple XIII.A Resolving Simpson’s Paradox XIII.B Measuring The Intrinsic Confounders XIII.C Recruiting the Missing Switch XIII.D Triphasic Regenerative Cardiology (TRC) Treatment Regimen XIII.E Road Ahead
Chapter 14: THE CONCLUSION XIV.A Goals Achieved XIV.B Beyond Goals – Serendipity Finds New Abode XIV.C Neocardiogenesis – A Second Coming
Chapter 15: AFTERWORD
APPENDIX: Neocardiogenesis- The Players
A. Aastrom Biosciences, Inc., Abbott Laboratories, Advanced Cell Technologies, Inc, Aldagen, Inc., Amorcyte, Inc AnGes MG, Inc, AngioB Limited, Angioblast Systems, Inc., Angiotech Pharmaceuticals, Inc., Ark Pharmaceuticals, Arteriocyte, Inc., Athersys, Inc., Axiogenesis, AG, Axordia, Ltd
B. Baxter Healthcare, BeFutur Biotechnologies SA, BioCardia, Inc., Bioheart, Inc., Boston Scientific Corporation.
C. California Stem Cell, Inc, Cardio, Inc., Cardio3 Biosciences, CardioGenesis, Corp., Cardion AG, CardioVascular BioTherapeutics, Inc., Cardium Therapeutics, Inc., Cellartis AB, Chiron / Novartis AG, Corautus/ Via Pharmaceuticals, Cordis Corp, Curis, Inc., Cytori Therapeutics, Inc.
E. EndGenitor Technologies, Inc., Endothelix, Inc., Endovasc/ Angiogenix/ Athenagen/ CoMentis, ES Cell International Pte Ltd, Euriogentec SA, EVGN European Vascular Genomics Network
G. Gamida Cell Ltd., Gencell/ Centelion/ Sanofi Aventis, Genentech, Inc., GenVec, Inc., Genzyme Corp, Geron Corporation, Geymonat S.p.A.
H. HealtheUniverse, Heart BioSystems GmbH, Hydra Biosciences, Inc., Hypertension Diagnostics, Inc.
I. Itamar Medical Ltd
L. Lazaron Biotechnologies (SA) Ltd, Lombard Medical Technologies PLC
M. Medcel Bioscience Ltd/ NovaThera Ltd, Medistem Laboratories, Inc, Medtronic, Inc., MG Biotherapeutics, Meridien Co. Ltd, Mesoblast Ltd., Millipore, Corp., Miltenyi Biotec GmbH, Mytogen, Inc
N. NanoCor Therapeutics Inc, Neuronyx, Inc., Novus Sanguis
O. Opexa Therapeutics, Osiris Therapeutics, Inc.
P. PLC Systems, Inc, PrimeGen Biotech LLC
R. RegeneRx Biopharmaceuticals, Inc., Regenetech, Inc, Reliance Life Sciences, Royan Institute
S. Saneron CCEL Therapeutics, Inc, Scios, Inc., Stem Cell Therapy International, Corp., Stemedica Cell Technologies, Inc., Sunway Biotech Co. Ltd., SynovisLife Technologies, Inc.
T. t2cure GmbH, TCA Cellular Therapy, LLC, TheraVitae Israel Ltd, Theregen, Inc., ThromboGenics NV
V. Valentis Inc. / Urigen / Inovio, Vascular Biogenics Ltd, Vasoplus Consortium, ViaCell, Inc., Vical, Inc., ViroMed Co. Ltd, VistaGen Therapeutics, Inc.
X. Xcell Center
Product samples
Samples for this product is available. Please Login/Register to download these samples.
Customers who bought this item also bought
Stem Cell Research in Cardiology
Cell Therapy - Technologies, Markets and Companies
Cell Therapy Clinical Trial Analysis
Heart Repair: A Placebo Fix? Or A Nocebo Mix?
Angiogenesis Modulators
Cell Therapy Markets
Stem Cell Research 2008
Interventional Cardiology Clinical Trial Analysis
Stem Cells in Regenerative Medicine 2008 Market Report
Angiogenesis Modulators: Strategies for Drug Discovery
Regenerative Medicine - Global Strategic Business Report
Current Clinical Applications and Trials of Stem Cell - Based Therapies
|
 |
|
|